We are focused on developing breakthrough therapies for COVID 19 and the treatment of Kidney Disease
Angiotensin Therapeutics Inc. is a privately held biopharmaceutical company focused on developing breakthrough therapies for COVID 19 and other potential Coronavirus outbreaks as well as for treatment of Kidney Disease
